Lean NAFLD is a special phenotypic closely correlated with metabolic syndrome (MS). The aim of this study is to investigate the MS development and the gender differences in lean NAFLD population.
GLP-1 drugs yielding greater weight loss have worse effects on lean body mass Patients on tirzepatide lost more muscle and other non-fat tissues than patients on semaglutide Exercise during treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results